Skip to main content

Astepro Allergy FDA Approval History

Last updated by Judith Stewart, BPharm on June 28, 2021.

FDA Approved: Yes (First approved June 17, 2021)
Brand name: Astepro Allergy
Generic name: azelastine
Dosage form: Nasal Spray
Company: Bayer HealthCare Pharmaceuticals Inc.
Treatment for: Allergic Rhinitis

Astepro Allergy (azelastine) is a nasal antihistamine for the treatment of seasonal allergic rhinitis.

Development timeline for Astepro Allergy

Jun 17, 2021Approval FDA Approves Astepro Allergy (azelastine) Nasal Spray for Over-the-Counter Use
Sep  2, 2009Approval Meda Receives FDA Approval of New Astepro (azelastine HCl) Nasal Spray 0.15%, the First and Only Once-Daily Nasal Antihistamine
Oct 17, 2008Approval FDA Approves Astepro for the Treatment of Seasonal Allergic Rhinitis

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.